Search the Studies

2 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number Title Protocol Status Min-Max Age Institute Keywords
19-I-0027A Phase 2 Randomized Double-Blinded Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in Subjects with Indolent Systemic MastocytosisParticipants currently recruited/enrolled18-75 YearsNIAIDMastocytosis
02-I-0277Regulation of the Proliferation and Survival of Normal and Neoplastic Human Mast CellsParticipants currently recruited/enrolled0-80 YearsNIAIDMastocytosis